OMGA - Omega Therapeutics GAAP EPS of -$0.64 misses by $0.02 revenue of $0.73M beats by $0.47M
- Omega Therapeutics press release ( NASDAQ: OMGA ): Q4 GAAP EPS of -$0.64 misses by $0.02 .
- Revenue of $0.73M (+421.4% Y/Y) beats by $0.47M .
For further details see:
Omega Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $0.73M beats by $0.47M